NCT02516098View on ClinicalTrials.gov

Determine the Bioequivalence of Two Formulations of Hyoscine Butylbromide.

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Healthy
Interventions
DRUG

hyoscine butylbromide

Trial Locations (1)

Unknown

Boehringer Ingelheim Investigational Site, Bloemfontein

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY